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Editorial on the Research Topic
Folded Synthetic Peptides for Biomedical Applications
Folded peptides—and peptide motifs within proteins—are abundant in living organisms, where
they are essential for the biological activities of the peptides and proteins. During the past
decades, numerous research programs have been dedicated to understanding the rules that govern
peptide folding. Simultaneously, a range of strategies have been established for the conformational
stabilization of bioactive peptides, as well as for the de novo design of peptides with defined
secondary structures. These methods are either based on the chemical modification of the peptide
backbone, such as cyclization and side chain stapling, or on the use of a range of non-proteinogenic
amino acids that, in a defined sequential arrangement, induce secondary structures in peptides.
Such building blocks include D- and other non-proteinogenic amino acids, as well as β- and
γ-amino acids.
This Research Topic comprises a collection of papers by an international group of 77 scientists
with a background in synthetic, analytical, computational, and medicinal chemistry, as well as in
biochemistry and pharmacology. Their research is presented here in a total of 11 papers (8 original
research reports and 3 reviews), covering diverse aspects of folded synthetic peptides. These studies
include the preparation and characterization of new peptide monomers with interesting folding
properties, the synthesis and conformational analysis of non-natural peptides, as well as the use
of folded peptidomimetics as molecular switches. Additionally, a range of biomedical applications,
such as antimicrobial, anti-inflammatory, antiangiogenic, and immune-stimulating activities, are
also reported.
Examples for the use of non-peptidic chemical moieties or non-natural amino acids for the
generation of folded synthetic peptides include the use of 1,4-disubstituted 1H-1,2,3-triazoles
(Schröder et al.) to mimic the amide bond. This bioisosteric replacement led to peptidodimetics
whose foldamer properties were confirmed by both instrumental analysis and computational
simulations. Similarly, two enantiomers of a bicyclic pyrrolidine-isoxazoline γ-amino acid were
used to prepare diastereoisomeric model peptides (Oliva et al.). NMR, FT-IR, circular dichroism
and molecular modeling studies confirmed that the (+) enantiomer was able to stabilize an
α-turn conformation. Conversely, Bucci et al. used syn-β2,3-diarylamino acids in conjunction
with S-alanine for the generation of foldameric antiparallel β-sheets. As in the study by Oliva
et al., foldamer properties were confirmed here as well by combining instrumental analysis and
theoretical calculations. Applications of synthetic peptides/peptidomimetics include their use as
molecular switches, utilizing the light-triggered reversible shift from one conformation to another.
In this context, Nuti et al. investigated the ability of a new photochromic azobenzene amino acid
derivative to act as a conformational switch, when inserted into a model peptide.
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A broad range of biopharmaceutical applications of synthetic
peptides are also reported in this Research Topic. Recent
applications of folded synthetic peptides targeting proteins of
the outer membrane of gram-negative bacteria are reviewed by
Robinson. In particular, synthetic β-hairpin mimetic peptides
were found to interact with β-barrel and β-jellyroll domains
in bacterial lipopolysaccharide transport and β-barrel folding
machine complexes, thus representing a new frontier in the
discovery of novel antimicrobial agents. Folded peptides are also
reported to target tumor angiogenesis. Zanella et al. present
oligopeptides, designed by structural analysis and computational
calculations, where Cα,α-disubstituted amino acids are exploited
to stabilize the helical conformation that is essential to bind
to the VEGF receptor at nanomolar concentration. Synthetic
peptides as cancer-targeting immune system engagers (ISErs) are
reported by Conibear et al. These molecule are generated using
a range of chemoselective ligations, including copper-catalyzed
azide-alkyne “click,” oxime, maleimide, and native chemical
ligations. Furthermore, anti-inflammatory peptides targeting the
interleukin-1 receptor (IL-1R) are reported by Geranurimi et al.
The authors describe the structure-activity relationships of 12
peptides, in which different configurations of the α-amino-γ-
lactam and β-hydroxy-α-amino-γ-lactam moieties were used to
conformationally constrain an IL-1R peptide ligand.
This Research Topic also presents articles on the use of folded
synthetic peptides for the design of functional biomaterials.
Hellmund and Koksch review the recent literature on the use of
self-assembling peptides as mimics of the extracellular matrix.
This is illustrated by peptide- and protein-based biomaterials
that are able to support proliferation and differentiation of stem
cells, demonstrating great potential of these peptides as tools
in regenerative medicine. Applications of N-acetyl-β3-peptides
to obtain innovative bio- and nanomaterials by supramolecular
self-assembly are reviewed by Kulkarni et al. Compared to
other organic and inorganic self-assembled systems, these
foldamers show advantages in terms of biocompatibility,
toxicity and functionalization potential. Last but not least,
Lammi et al. report a strategy to increase the stability and anti-
diabetic properties of hempseed protein hydrolysates. This was
achieved through encapsulation of hempseed hydrolysates
into ionic self-complementary RADA16 peptide-based
hydrogels. This study also evaluated the synergistic activity
of RADA16-hemp hydrogels and sitagliptin, an orally available
DPPIV inhibitor.
As a collection, the papers of this Research Topic demonstrate
the broad impact of folded synthetic peptides on various fields
of biological and biomedical research. It can be expected that
research on folded synthetic peptides will continue to result in
applications in medicinal chemistry and drug design, as well as
the design of novel biomaterials.
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